Summary
Coagulation factor VII activity (FVIIC) is a risk indicator for cardiovascular disease.
It is related to serum-triglycerides and the R/Q353 polymorphism (alleles R and Q)
in the gene coding for factor VII is strongly associated with factor VII. The association
of serum- triglycerides with factor VII may differ between the genotypes, but the
results of earlier studies were inconsistent and did not include older people. We
studied FVII, triglycerides and the R/Q353 polymorphism in the Rotterdam Study.
In 1158 older subjects (489 men and 669 women) FVIIC, factor VII: Chr, serum-triglycerides
and the R/Q353-genotype were determined.
In women triglycerides were positively associated with FVIIChr and FVIIC (FVIIChr: β = 12.4 % PP/mmol/L, CI: 10.3-14.5; FVII:C: β = 13.1% PP/mmol/L, CI: 10.4-15.8). These associations varied by genotype (FVII:Chr: RR: β = 11.7, CI: 9.6-13.8, RQ/QQ: β = 7.9, CI: 4.6-11.2; FVII:C: RR: β = 12.5, CI: 9.5-15.5, RQ/QQ: β = 6.4, CI: 1.4-11.4).
In men, the associations of FVII:Chr and FVII:C with triglycerides were weaker (FVII:Chr: β = 5.9, CI: 4.1-7.7; FVII:C: β = 8.7, CI: 6.2-11.2). There was no difference between the genotype groups.
These results suggest that only in older women the strength of the association of
factor VII with serum-triglycerides varies according to genotype of the R/Q353 polymorphism.
